Singapore markets closed
Straits Times Index
3,264.53 -35.51 (-1.08%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
62,258.39 -1,275.29 (-2.01%) CMC Crypto 200
1,286.02 -8.65 (-0.67%)
ANIP Oct 2024 75.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:04PM EDT. Market open.
| Previous close | 4.3700 |
| Open | 4.3700 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 75.00 |
| Expiry date | 2024-10-18 |
| Day's range | 4.3700 - 4.3700 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksRocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
Rocket Pharmaceuticals' (RCKT) first-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the quarter.
ZacksApellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Apellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus Estimate and revenues beat the same, driven by strong sales of Syfovre.
ZacksANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
ANI Pharmaceuticals' (ANIP) revenues in the first quarter of 2024 are likely to have been driven by increased sales of its lead product, Cortrophin Gel, as well as growth in its generics business.
© 2024 Yahoo. All rights reserved.